1939.3000 3.70 (0.19%)
NSE Oct 10, 2025 15:31 PM
Volume: 867.4K
 

1939.30
0.19%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 8.4% YoY to | 2165.6 crore (I-direct estimate: | 2201.3 crore) mainly due to 33% decline in the US to | 704 crore (Idirect estimate: | 727.5 crore) on the back of high base of gZetia exclusivity in Q1FY18. Europe, on the other hand, grew 35.6% YoY to | 219.8 crore (I-direct estimate: | 186.4 crore). India business grew 7.6% YoY to | 663.3 crore (I-direct estimate: | 690.4 crore) EBITDA margins contracted 842 bps YoY to 16.0% (I-direct estimate: 17.0%) attributable to higher base of gZetia exclusivity. EBITDA...
Glenmark Pharmaceuticals Ltd. is trading below its 30 day SMA of 2014.4
More from Glenmark Pharmaceuticals Ltd.
Recommended